New study pinpoints oliceridine dose to keep blood pressure steady during intubation
NCT ID NCT07154979
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested different doses of oliceridine, a painkiller, to find the amount that best prevents sudden rises in blood pressure and heart rate when a breathing tube is placed during anesthesia. Researchers enrolled 58 adults having elective surgery and adjusted doses based on age. The goal was to identify the effective dose for safer anesthesia induction.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
oliceridine (TRV130)
What this could lead to
If successful, this could help doctors choose the safest dose of oliceridine to prevent dangerous blood pressure spikes during anesthesia, especially for older patients.
What could go wrong
This is a small, completed dose-finding study, not a large trial testing long-term outcomes. The results may not apply to all patients or settings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OLICERIDINE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Tianmen First People's Hospital
Tianmen, Hubei, 431700, China